Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy.
Wada Y, Kamata M, Miyasaka R, Abe T, Kawamura S, Takeuchi K, Aoyama T, Oda T, Takeuchi Y.
Int J Mol Sci. 2023 May 8;24(9):8432. doi: 10.3390/ijms24098432.
PMID:37176142
Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report.
Zhang X, Wang H, Li J, Zhou F, Zhao M, Su T.
BMC Nephrol. 2024 Aug 30;25(1):284. doi: 10.1186/s12882-024-03732-6.
PMID:39215250
Diffuse endocapillary proliferative glomerulonephritis and parvovirus B19 infection. A causal relationship?
García Chumillas V, González Martínez MÁ, Caba Molina M.
Med Clin (Barc). 2024 Jul 12;163(1):46-47. doi: 10.1016/j.medcli.2023.12.028. Epub 2024 Feb 27.
PMID:38418308
Hepatitis E Virus-Associated Endocapillary Proliferative Glomerulonephritis in an Immunocompetent Adult.
Miyazaki T, Hirai T, Nishida H, Fujii T, Isomura A, Nagahama K.
Kidney Int Rep. 2025 Jun 16;10(8):2871-2872. doi: 10.1016/j.ekir.2025.06.028. eCollection 2025 Aug.
PMID:40814596
The severity of glomerular endothelial cell injury is associated with infiltrating macrophage heterogeneity in endocapillary proliferative glomerulonephritis.
Arai M, Mii A, Kashiwagi T, Shimizu A, Sakai Y.
Sci Rep. 2021 Jun 25;11(1):13339. doi: 10.1038/s41598-021-92655-5.